Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aphria Inc. APHA

Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints of federal prohibition. It has some U.S. exposure through the acquisition of SweetWater, a craft brewer


NDAQ:APHA - Post by User

Post by Savage97on Nov 01, 2020 5:44pm
233 Views
Post# 31820664

King Cannabis Irwin Simon Explains Business Strategy

King Cannabis Irwin Simon Explains Business Strategy
Our overall strategy is to leverage our expertise and capabilities to drive market share in Canada and internationally in order to achieve profitable growth and build sustainable, longterm shareholder value. We are focused on maximizing growth in net sales, profitability and managing cash flow in our identified core markets in Canada, Germany and Latin America. In order to ensure the longterm sustainable growth of our Company, we continue to drive category leadership and assess growth opportunities with the introduction of innovative new products, increase our market share, maintain a strong financial position and manage our cost of goods and expenses with a focus on being the lowcost, highquality producer.
Within Canada, Aphria is focused on gaining market share in the Canadian cannabis industry by executing on our strategic priorities through entering new product categories that possess the most consumer demand, while leveraging our expertise to develop brands that are truly differentiated from our competitors and optimizing our production to continue to be the highquality, lowcost producer we are today. Internationally, we are focused on business activities that provide a return on investment in the near term without being capital intensive. We intend to continue to maximize the utilization of our existing assets and investments in connection with the development and execution of our growth plans, while leveraging our cannabis expertise and wellestablished Aphria medical brand. By building on this foundation, we strive to take a leadership position in the industry.
<< Previous
Bullboard Posts
Next >>